Zebrafish model study explains clinical phenotype similarity in megalencephalic leukoencephalopathy patients

The experts Alejandro Barrallo and Raúl Estévez, from the Department of Physiological Sciences II at the University of Barcelona.

Megalencephalic leukoencephalopathy (MLC) is a genetic neurodegenerative disorder affecting the myelin that remains quite unknown. To date, there is not any treatment for patients. This rare disease is caused by mutations in MLC1 and GlialCAM and produces megalencephaly, spasticity and ataxia in humans. A new study of the University of Barcelona, published in the journal Human Molecular Genetics, first describes a phenotype of this human disease through the study of genetically-modified zebrafish models.

The article is signed by Raúl Estévez, Sònia Sirisi and Alejandro Barrallo, from the Department of Physiological Sciences II on the Bellvitge Health Sciences Campus at the University of Barcelona (UB) and members of the Centre for Biomedical Network Research on Rare Diseases (CIBERER); and Virginia Nunes, lecturer of Genetics at UB, researcher at the Bellvitge Biomedical Research Centre (IDIBELL) and member of CIBERER, among other experts.

Raúl Estévez explains that "patients with recessive mutations in either MLC1 or GLIALCAM show the same clinical phenotype". "However, it is known that gene GlialCAM regulates the activity of two proteins, MLC1 and the chloride channel ClC-2. Therefore, the absence of the gene GlialCAM should produce a severer phenotype than the lack of MLC1".

In order to understand this contradiction, the research group led by Raúl Estévez and Alejandro Barrallo compared genetically-modified zebrafish and mice models —in other words, knock-out organisms that, in this case, do not express the gene MLC1— with the brain biopsy from an MLC patient.

Conclusions state that the lack of MLC1 expression causes the delocalization of protein GlialCAM which mimics neuronal activity in all studied models. Genetic modification in zebrafish models is cheap and easy, so authors point out that future research on these animal models will contribute to understand the molecular relationship that exists between the proteins involved in the physiopathology of megalencephalic leukoencephalopathy.

The article is signed by Raúl Estévez, Sònia Sirisi and Alejandro Barrallo, from the Department of Physiological Sciences II on the Bellvitge Health Sciences Campus at the University of Barcelona (UB) and members of the Centre for Biomedical Network Research on Rare Diseases (CIBERER); and Virginia Nunes, lecturer of Genetics at UB, researcher at the Bellvitge Biomedical Research Centre (IDIBELL) and member of CIBERER, among other experts.

Raúl Estévez explains that "patients with recessive mutations in either MLC1 or GLIALCAM show the same clinical phenotype". "However, it is known that gene GlialCAM regulates the activity of two proteins, MLC1 and the chloride channel ClC-2. Therefore, the absence of the gene GlialCAM should produce a severer phenotype than the lack of MLC1".

In order to understand this contradiction, the research group led by Raúl Estévez and Alejandro Barrallo compared genetically-modified zebrafish and mice models —in other words, knock-out organisms that, in this case, do not express the gene MLC1— with the brain biopsy from an MLC patient.

Conclusions state that the lack of MLC1 expression causes the delocalization of protein GlialCAM which mimics neuronal activity in all studied models. Genetic modification in zebrafish models is cheap and easy, so authors point out that future research on these animal models will contribute to understand the molecular relationship that exists between the proteins involved in the physiopathology of megalencephalic leukoencephalopathy.

More information: "Megalencephalic Leukoencephalopathy with subcortical Cysts protein 1 regulates glial surface localization of GLIALCAM from fish to humans." Sirisi S, Folgueira M, López-Hernández T, Minieri L, Pérez-Rius C, Gaitán-Peñas H, Zang J, Martínez A, Capdevila-Nortes X, de la Villa P, Roy U, Alia , Neuhauss S5, Ferroni S, Nunes V, Estévez R, Barrallo-Gimeno A. Human Molecular Genetics. 2014 May 12. pii: ddu231. www.ncbi.nlm.nih.gov/pubmed/24824219

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Throwing a loop to silence gene expression

4 hours ago

All human cells contain essentially the same DNA sequence – their genetic information. How is it possible that shapes and functions of cells in the different parts of the body are so different? While every cell's DNA contains ...

A nucleotide change could initiate fragile X syndrome

Sep 01, 2014

Researchers reveal how the alteration of a single nucleotide—the basic building block of DNA—could initiate fragile X syndrome, the most common inherited form of intellectual disability. The study appears ...

Gene clues to glaucoma risk

Aug 31, 2014

Scientists on Sunday said they had identified six genetic variants linked to glaucoma, a discovery that should help earlier diagnosis and better treatment for this often-debilitating eye disease.

User comments